EXCEGRAN Side Effects

6992281-5 | Fracture
on Sep 14, 2010 Female patient from JAPAN , 57 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: fracture (What is fracture?). Excegran dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), DEPAS (View Depas Review and Depas Label ), SOLANAX (View Solanax Review and Solanax Label ). Patient was hospitalized.

6984316-0 | Oculomucocutaneous Syndrome
Patient was taking Excegran (View Usage). Patient had the following side effects: oculomucocutaneous syndrome on Sep 09, 2010 from JAPAN Additional patient health information: Male patient , 40 years of age, weighting 143.3 lb, was diagnosed with epilepsy (What is epilepsy?) and. Excegran dosage: . During the same period patient was treated with TARCEVA (View Tarceva Review and Tarceva Label ), CRAVIT (View Cravit Review and Cravit Label ), LOXONIN (View Loxonin Review and Loxonin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), BENZALIN (View Benzalin Review and Benzalin Label ), PREDONINE (View Predonine Review and Predonine Label ).

6971228-1 | Lip Oedema, Pharyngeal Oedema, Rash
Adverse event was reported on Sep 02, 2010 by a Female patient taking Excegran (View Usage) (Dosage: ) . Location: JAPAN , 75 years of age, weighting 106.9 lb, After Excegran was administered, patient had the following side effects: lip oedema, pharyngeal oedema, rash (What is rash?). During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ). Patient was hospitalized.

6970079-1 | Renal Failure Acute
on Sep 01, 2010 Female patient from JAPAN , 76 years of age, was treated with Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Excegran dosage: . Patient was hospitalized.


6968673-7 | Neutrophil Count Decreased
on Aug 23, 2010 Female patient from JAPAN , 81 years of age, was treated with Excegran (View Usage). Patient had the following side effects: neutrophil count decreased. Excegran dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), MADOPAR (View Madopar Review and Madopar Label ), PLETAL (View Pletal Review and Pletal Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), CINAL (View Cinal Review and Cinal Label ). Patient was hospitalized.

6944394-1 | Fracture
Patient was taking Excegran (View Usage). After Excegran was administered, patient had the following side effects: fracture (What is fracture?) on Aug 20, 2010 from JAPAN Additional patient health information: Female patient , 57 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Excegran dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), DEPAS (View Depas Review and Depas Label ), SOLANAX (View Solanax Review and Solanax Label ). Patient was hospitalized.

6934156-3 | Calculus Urinary
Adverse event was reported on Aug 17, 2010 by a Male patient taking Excegran (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: JAPAN , 26 years of age, Patient experienced the following unwanted or unexpected effects: calculus urinary. During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), TEGRETOL (View Tegretol Review and Tegretol Label ).

6920927-6 | Agranulocytosis
on Aug 10, 2010 Female patient from JAPAN , 46 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Excegran (View Usage). Patient had the following side effects: agranulocytosis. Excegran dosage: 100 Mg Daily. Patient was hospitalized.

6918466-1 | Hypohidrosis, Pyrexia
on Aug 04, 2010 Female patient from JAPAN , 36 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Excegran (View Usage). After Excegran was administered, patient had the following side effects: hypohidrosis, pyrexia. Excegran dosage: .

6907836-3 | Hypohidrosis, Pyrexia
Patient was taking Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: hypohidrosis, pyrexia on Jul 30, 2010 from JAPAN Additional patient health information: Male patient , 36 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Excegran dosage: .

6810262-9 | Platelet Count Decreased
Adverse event was reported on Jun 18, 2010 by a Male patient taking Excegran (View Usage) (Dosage: 180 Mg Daily) was diagnosed with epilepsy (What is epilepsy?) and. Location: JAPAN , child 6 years of age, Patient had the following side effects: platelet count decreased. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), LANDSEN (View Landsen Review and Landsen Label ). Patient was hospitalized.

6791090-X | Interstitial Lung Disease
on Jun 17, 2010 Male patient from JAPAN , 71 years of age, was treated with Excegran (View Usage). After Excegran was administered, patient had the following side effects: interstitial lung disease. Excegran dosage: . During the same period patient was treated with PROHEPARUM (View Proheparum Review and Proheparum Label ), CERNILTON (View Cernilton Review and Cernilton Label ), GLYCYRON (View Glycyron Review and Glycyron Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), URIEF (View Urief Review and Urief Label ), HERBESSER R (View Herbesser R Review and Herbesser R Label ).

6760927-2 | Interstitial Lung Disease
on Jun 03, 2010 Male patient from JAPAN , 60 years of age, was treated with Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Excegran dosage: .

6758843-5 | Rhabdomyolysis
Patient was taking Excegran (View Usage). Patient had the following side effects: rhabdomyolysis on Jun 03, 2010 from JAPAN Additional patient health information: Male patient , 80 years of age, . Excegran dosage: . Patient was hospitalized.

6739172-2 | Haemoglobin Decreased
Adverse event was reported on May 19, 2010 by a Female patient taking Excegran (View Usage) (Dosage: ) . Location: JAPAN , 40 years of age, After Excegran was administered, patient had the following side effects: haemoglobin decreased.

6732454-X | Platelet Count Decreased
on May 06, 2010 Male patient from JAPAN , child 6 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Excegran dosage: 180 Mg Daily. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), LANDSEN (View Landsen Review and Landsen Label ). Patient was hospitalized.

6731681-5 | Agranulocytosis
on May 14, 2010 Male patient from JAPAN , 18 years of age, was diagnosed with temporal lobe epilepsy and was treated with Excegran (View Usage). Patient had the following side effects: agranulocytosis. Excegran dosage: . During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

6690781-9 | Cough, Pyrexia
Patient was taking Excegran (View Usage). After Excegran was administered, patient had the following side effects: cough, pyrexia on Apr 15, 2010 from JAPAN Additional patient health information: Female patient , 26 years of age, . Excegran dosage: . Patient was hospitalized.

6677018-1 | Liver Disorder
Adverse event was reported on Apr 05, 2010 by a Female patient taking Excegran (View Usage) (Dosage: ) . Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: liver disorder.

6618278-2 | Red Blood Cell Count Decreased
on Mar 02, 2010 Female patient from JAPAN , child 9 years of age, was diagnosed with epilepsy (What is epilepsy?), red blood cell count decreased and was treated with Excegran (View Usage). Patient had the following side effects: red blood cell count decreased. Excegran dosage: . During the same period patient was treated with BLOOD TRANSFUSION (View Blood Transfusion Review and Blood Transfusion Label ). Patient was hospitalized.

6595526-9 | Toxic Epidermal Necrolysis
on Feb 17, 2010 Male patient from JAPAN , 48 years of age, was treated with Excegran (View Usage). After Excegran was administered, patient had the following side effects: toxic epidermal necrolysis. Excegran dosage: . Patient was hospitalized.

6520336-8 | Agranulocytosis, Rash
Patient was taking Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, rash (What is rash?) on Dec 24, 2009 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Excegran dosage: . Patient was hospitalized.

6467809-4 | Stevens-johnson Syndrome
Adverse event was reported on Nov 26, 2009 by a Male patient taking Excegran (View Usage) (Dosage: ) . Location: JAPAN , 61 years of age, Patient had the following side effects: stevens-johnson syndrome. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ).

6456741-8 | Hyperglycaemia
on Nov 20, 2009 Male patient from JAPAN , 53 years of age, was diagnosed with diabetes mellitus and was treated with Excegran (View Usage). After Excegran was administered, patient had the following side effects: hyperglycaemia. Excegran dosage: . During the same period patient was treated with INSULIN (52 Units) (View Insulin Review and Insulin Label ), LEVEMIR (View Levemir Review and Levemir Label ), NOVORAPID (View Novorapid Review and Novorapid Label ). Patient was hospitalized.

6449316-8 | Oculomucocutaneous Syndrome
on Nov 16, 2009 Female patient from JAPAN , 32 years of age, was treated with Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: oculomucocutaneous syndrome. Excegran dosage: .

6448163-0 | Toxic Epidermal Necrolysis
Patient was taking Excegran (View Usage). Patient had the following side effects: toxic epidermal necrolysis on Nov 16, 2009 from JAPAN Additional patient health information: Male patient , 53 years of age, . Excegran dosage: .

6442667-2 | Blood Glucose Increased
Adverse event was reported on Nov 10, 2009 by a Male patient taking Excegran (View Usage) (Dosage: ) . Location: JAPAN , 53 years of age, After Excegran was administered, patient had the following side effects: blood glucose increased. During the same period patient was treated with INSULIN (52 Units) (View Insulin Review and Insulin Label ). Patient was hospitalized.

6429088-3 | Rash
on Oct 29, 2009 Female patient from JAPAN , child 9 years of age, was treated with Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Excegran dosage: . Patient was hospitalized.

6407078-4 | Neuroleptic Malignant Syndrome
on Oct 14, 2009 Male patient from JAPAN , child 1 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Excegran (View Usage). Patient had the following side effects: neuroleptic malignant syndrome. Excegran dosage: . During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ). Patient was hospitalized.

6387195-8 | Neuroleptic Malignant Syndrome
Patient was taking Excegran (View Usage). After Excegran was administered, patient had the following side effects: neuroleptic malignant syndrome on Sep 30, 2009 from JAPAN Additional patient health information: Male patient , child 1 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Excegran dosage: . During the same period patient was treated with LIDOCAINE (View Lidocaine Review and Lidocaine Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ). Patient was hospitalized.

6382658-3 | Neuroleptic Malignant Syndrome
Adverse event was reported on Sep 24, 2009 by a Female patient taking Excegran (View Usage) (Dosage: ) was diagnosed with convulsion and. Location: JAPAN , child 1 years of age, Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome.

6339894-1 | Nephrolithiasis
on Aug 28, 2009 Male patient from JAPAN , 30 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Excegran (View Usage). Patient had the following side effects: nephrolithiasis. Excegran dosage: . Patient was hospitalized.

6327081-2 | Alanine Aminotransferase Increased, Dermatitis Exfoliative, Erythema Infectiosum, Hepatic Function Abnormal, Lymphocyte Stimulation Test Positive, Streptococcal Infection
on Jul 03, 2009 Female patient from JAPAN , child 7 years of age, was diagnosed with convulsion, streptococcal infection (What is streptococcal infection?) and was treated with Excegran (View Usage). After Excegran was administered, patient had the following side effects: alanine aminotransferase increased, dermatitis exfoliative, erythema infectiosum, hepatic function abnormal, lymphocyte stimulation test positive, streptococcal infection (What is streptococcal infection?). Excegran dosage: . During the same period patient was treated with FLUTICASONE (View Fluticasone Review and Fluticasone Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6297835-X | Anaemia
Patient was taking Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia on Jul 23, 2009 from JAPAN Additional patient health information: Male patient , 50 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Excegran dosage: . Patient was hospitalized.

6293194-7 | Platelet Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Jul 28, 2009 by a Male patient taking Excegran (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: JAPAN , 20 years of age, Patient had the following side effects: platelet count decreased, white blood cell count decreased. During the same period patient was treated with MAGMITT (View Magmitt Review and Magmitt Label ), FAMOGAST (View Famogast Review and Famogast Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), MYSLEE (View Myslee Review and Myslee Label ).

6293188-1 | Nephrolithiasis
on Jul 29, 2009 Female patient from JAPAN , 65 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Excegran (View Usage). After Excegran was administered, patient had the following side effects: nephrolithiasis. Excegran dosage: . During the same period patient was treated with TAKEPRON (View Takepron Review and Takepron Label ), NORVASC (View Norvasc Review and Norvasc Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), PANTOSIN (View Pantosin Review and Pantosin Label ), SERMION (View Sermion Review and Sermion Label ).

6277016-6 | Hypohidrosis, Pyrexia, Rhabdomyolysis
on Jul 16, 2009 Male patient from JAPAN , 38 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: hypohidrosis, pyrexia, rhabdomyolysis. Excegran dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6246261-8 | Toxic Epidermal Necrolysis
Patient was taking Excegran (View Usage). Patient had the following side effects: toxic epidermal necrolysis on Jun 19, 2009 from JAPAN Additional patient health information: Male patient , child 4 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Excegran dosage: . During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ), ALEVIATIN (Dose Gradually Increased) (View Aleviatin Review and Aleviatin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

6241561-X | Hypersensitivity
Adverse event was reported on Jun 18, 2009 by a Female patient taking Excegran (View Usage) (Dosage: ) . Location: JAPAN , 68 years of age, After Excegran was administered, patient had the following side effects: hypersensitivity.

6235021-X | Oculomucocutaneous Syndrome
on Jun 12, 2009 Female patient from JAPAN , child 8 years of age, was diagnosed with tuberous sclerosis (What is tuberous sclerosis?) and was treated with Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: oculomucocutaneous syndrome. Excegran dosage: . During the same period patient was treated with SELENICA R (View Selenica-r Review and Selenica-r Label ), MYSTAN (View Mystan Review and Mystan Label ). Patient was hospitalized.

6226693-4 | Hepatic Function Abnormal, Pyrexia, Toxic Skin Eruption, Vitamin B12 Deficiency
on Jun 04, 2009 Male patient from JAPAN , 39 years of age, was treated with Excegran (View Usage). Patient had the following side effects: hepatic function abnormal, pyrexia, toxic skin eruption, vitamin b12 deficiency. Excegran dosage: . Patient was hospitalized.

6218293-7 | Granulocyte Count Decreased, Platelet Count Decreased, Rash, Vomiting
Patient was taking Excegran (View Usage). After Excegran was administered, patient had the following side effects: granulocyte count decreased, platelet count decreased, rash (What is rash?), vomiting on Apr 24, 2009 from JAPAN Additional patient health information: Female patient , 17 years of age, . Excegran dosage: . Patient was hospitalized.

6212449-5 | Stevens-johnson Syndrome
Adverse event was reported on May 28, 2009 by a Male patient taking Excegran (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. During the same period patient was treated with ZYLORIC (View Zyloric Review and Zyloric Label ), GASTER D (View Gaster D Review and Gaster D Label ), MICARDIS (View Micardis Review and Micardis Label ). Patient was hospitalized.

6211925-9 | Toxic Epidermal Necrolysis
on May 28, 2009 Male patient from JAPAN , child 4 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Excegran (View Usage). Patient had the following side effects: toxic epidermal necrolysis. Excegran dosage: . During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), PHENYTOIN (Dose Gradually Increased) (View Phenytoin Review and Phenytoin Label ). Patient was hospitalized.

6199753-4 | Oculomucocutaneous Syndrome
on May 20, 2009 Female patient from JAPAN , 29 years of age, was treated with Excegran (View Usage). After Excegran was administered, patient had the following side effects: oculomucocutaneous syndrome. Excegran dosage: .

6197318-1 | Rhabdomyolysis
Patient was taking Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis on May 13, 2009 from JAPAN Additional patient health information: Male patient , 24 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Excegran dosage: . During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ). Patient was hospitalized.

6191426-7 | Rhabdomyolysis
Adverse event was reported on May 12, 2009 by a Male patient taking Excegran (View Usage) (Dosage: ) . Location: JAPAN , 24 years of age, Patient had the following side effects: rhabdomyolysis.

6174089-6 | Granulocyte Count Decreased, Platelet Count Decreased, Rash, Vomiting
on Apr 24, 2009 Female patient from JAPAN , 17 years of age, was treated with Excegran (View Usage). After Excegran was administered, patient had the following side effects: granulocyte count decreased, platelet count decreased, rash (What is rash?), vomiting. Excegran dosage: . Patient was hospitalized.

6168619-8 | Nausea, Neutrophil Count Decreased, Platelet Count Decreased, Rash
on Apr 22, 2009 Female patient from JAPAN , 17 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Excegran (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), neutrophil count decreased, platelet count decreased, rash (What is rash?). Excegran dosage: . Patient was hospitalized.

6164266-2 | Feeding Disorder Neonatal, Weight Gain Poor
Patient was taking Excegran (View Usage). Patient had the following side effects: feeding disorder neonatal, weight gain poor on Apr 09, 2009 from JAPAN Additional patient health information: Male patient , weighting 6.22 lb, . Excegran dosage: . Patient was hospitalized.